| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
100,490,000 |
| Market
Cap: |
2.86(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$19.98 - $42.09 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. Co.'s primary clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRss). Co. is also developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRss for X-linked adrenoleukodystrophy, a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1,240 |
1,240 |
| Total Buy Value |
$0 |
$0 |
$29,943 |
$29,943 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
364,731 |
476,090 |
511,511 |
2,191,279 |
| Total Sell Value |
$12,052,189 |
$15,984,363 |
$16,968,897 |
$113,271,153 |
| Total People Sold |
4 |
5 |
5 |
8 |
| Total Sell Transactions |
4 |
8 |
11 |
33 |
| End Date |
2025-11-09 |
2025-08-08 |
2025-02-07 |
2024-02-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mancini Marianna |
Chief Operating Officer |
• – – |
2026-01-05 |
4 |
S |
$32.29 |
$1,901,405 |
D/D |
(57,661) |
409,190 |
|
18% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2026-01-05 |
4 |
S |
$32.09 |
$1,896,969 |
D/D |
(57,661) |
189,891 |
|
18% |
|
| Lian Brian |
President & CEO |
• • – |
2026-01-05 |
4 |
S |
$32.29 |
$7,692,121 |
D/D |
(233,409) |
2,499,291 |
|
18% |
|
| Rouan Sarah Kathryn |
|
– • – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,150 |
4,390 |
|
- |
|
| Macartney Lawson |
|
– • – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,150 |
51,115 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
73,049 |
466,851 |
|
- |
|
| Foehr Matthew W |
|
– • – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,150 |
135,186 |
|
- |
|
| Foehr Matthew W |
|
– • – |
2026-01-02 |
4 |
S |
$35.11 |
$561,694 |
D/D |
(16,000) |
132,036 |
|
26% |
|
| Foehr Matthew W |
|
– • – |
2026-01-02 |
4 |
OE |
$3.33 |
$53,280 |
D/D |
16,000 |
148,036 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
73,049 |
247,532 |
|
- |
|
| Rowland Charles A Jr |
|
– • – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,150 |
33,150 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
302,480 |
2,732,700 |
|
- |
|
| Singleton J Matthew |
|
– • – |
2026-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,150 |
12,650 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2025-10-28 |
4 |
S |
$35.01 |
$1,364,923 |
D/D |
(38,989) |
2,419,109 |
|
25% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-10-28 |
4 |
S |
$35.00 |
$216,492 |
D/D |
(6,185) |
382,467 |
|
25% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-10-28 |
4 |
S |
$35.00 |
$216,481 |
D/D |
(6,185) |
173,592 |
|
25% |
|
| Rowland Charles A Jr |
|
– • – |
2025-10-27 |
4 |
S |
$35.57 |
$2,134,278 |
D/D |
(60,000) |
30,000 |
|
27% |
|
| Rowland Charles A Jr |
|
– • – |
2025-10-27 |
4 |
A |
$4.48 |
$306,640 |
D/D |
60,000 |
90,000 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2025-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
70,084 |
2,458,098 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,117 |
388,652 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,117 |
179,777 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-07-03 |
4 |
S |
$27.77 |
$118,473 |
D/D |
(4,266) |
377,535 |
|
-34% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-07-03 |
4 |
S |
$27.76 |
$118,428 |
D/D |
(4,266) |
168,660 |
|
-34% |
|
| Lian Brian |
President & CEO |
• • – |
2025-07-03 |
4 |
S |
$27.80 |
$747,633 |
D/D |
(26,889) |
2,388,014 |
|
-34% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,667 |
381,801 |
|
- |
|
210 Records found
|
|
Page 1 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
2.15 (8.18%) 
